Main variables;Branches of activity;Total
No. of companies carrying out R&D in Biotechnology;Total Companies;1,348
No. of companies carrying out R&D in Biotechnology;Services;818
No. of companies carrying out R&D in Biotechnology;Industry and Construction;427
No. of companies carrying out R&D in Biotechnology;Agriculture;103
%Companies according to biotechnology used: Genetic code;Total Companies;31.0
%Companies according to biotechnology used: Genetic code;Services;39.9
%Companies according to biotechnology used: Genetic code;Industry and Construction;15.9
%Companies according to biotechnology used: Genetic code;Agriculture;22.9
%Companies according to biotechnology used: Functional units;Total Companies;38.4
%Companies according to biotechnology used: Functional units;Services;42.8
%Companies according to biotechnology used: Functional units;Industry and Construction;33.9
%Companies according to biotechnology used: Functional units;Agriculture;22.2
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total Companies;21.7
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Services;26.3
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Industry and Construction;13.5
%Companies according to biotechnology used: Cellular and tissue culturing and engineering;Agriculture;19.1
%Companies according to biotechnology used: Bioprocesses;Total Companies;50.3
%Companies according to biotechnology used: Bioprocesses;Services;40.0
%Companies according to biotechnology used: Bioprocesses;Industry and Construction;74.4
%Companies according to biotechnology used: Bioprocesses;Agriculture;33.0
%Companies according to biotechnology used: Sub-cellular organisms;Total Companies;8.2
%Companies according to biotechnology used: Sub-cellular organisms;Services;11.1
%Companies according to biotechnology used: Sub-cellular organisms;Industry and Construction;4.3
%Companies according to biotechnology used: Sub-cellular organisms;Agriculture;2.0
%Companies according to biotechnology used: Bio-computing;Total Companies;24.1
%Companies according to biotechnology used: Bio-computing;Services;34.1
%Companies according to biotechnology used: Bio-computing;Industry and Construction;9.2
%Companies according to biotechnology used: Bio-computing;Agriculture;6.9
%Companies according to biotechnology used: Nanobiotechnology;Total Companies;11.8
%Companies according to biotechnology used: Nanobiotechnology;Services;16.2
%Companies according to biotechnology used: Nanobiotechnology;Industry and Construction;5.8
%Companies according to biotechnology used: Nanobiotechnology;Agriculture;1.0
%Companies according to biotechnology used: Other;Total Companies;16.4
%Companies according to biotechnology used: Other;Services;18.3
%Companies according to biotechnology used: Other;Industry and Construction;7.8
%Companies according to biotechnology used: Other;Agriculture;36.9
Companies in which biotechnology activities are: Main and/or exclusive;Total Companies;661
Companies in which biotechnology activities are: Main and/or exclusive;Services;529
Companies in which biotechnology activities are: Main and/or exclusive;Industry and Construction;109
Companies in which biotechnology activities are: Main and/or exclusive;Agriculture;23
Companies in which biotechnology activities are: A secondary line of business;Total Companies;188
Companies in which biotechnology activities are: A secondary line of business;Services;105
Companies in which biotechnology activities are: A secondary line of business;Industry and Construction;69
Companies in which biotechnology activities are: A secondary line of business;Agriculture;14
Companies in which biotechnology activities are: A tool necessary for production;Total Companies;500
Companies in which biotechnology activities are: A tool necessary for production;Services;184
Companies in which biotechnology activities are: A tool necessary for production;Industry and Construction;250
Companies in which biotechnology activities are: A tool necessary for production;Agriculture;66
%Company by field(s) of ultimate application of biotechnology use: Human Health;Total Companies;45.8
%Company by field(s) of ultimate application of biotechnology use: Human Health;Services;61.6
%Company by field(s) of ultimate application of biotechnology use: Human Health;Industry and Construction;25.5
%Company by field(s) of ultimate application of biotechnology use: Human Health;Agriculture;5.0
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total Companies;15.3
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Services;16.4
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Industry and Construction;10.9
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Agriculture;24.2
%Company by field(s) of ultimate application of biotechnology use: Food products;Total Companies;31.5
%Company by field(s) of ultimate application of biotechnology use: Food products;Services;21.0
%Company by field(s) of ultimate application of biotechnology use: Food products;Industry and Construction;51.7
%Company by field(s) of ultimate application of biotechnology use: Food products;Agriculture;32.1
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Total Companies;23.7
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Services;20.2
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Industry and Construction;21.3
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production;Agriculture;60.7
%Company by field(s) of ultimate application of biotechnology use: Environment;Total Companies;15.5
%Company by field(s) of ultimate application of biotechnology use: Environment;Services;16.1
%Company by field(s) of ultimate application of biotechnology use: Environment;Industry and Construction;15.1
%Company by field(s) of ultimate application of biotechnology use: Environment;Agriculture;13.1
%Company by field(s) of ultimate application of biotechnology use: Industry;Total Companies;13.4
%Company by field(s) of ultimate application of biotechnology use: Industry;Services;14.2
%Company by field(s) of ultimate application of biotechnology use: Industry;Industry and Construction;14.2
%Company by field(s) of ultimate application of biotechnology use: Industry;Agriculture;4.0
Personnel in R&D in biotechnology (no. of persons);Total Companies;15,744
Personnel in R&D in biotechnology (no. of persons);Services;9,783
Personnel in R&D in biotechnology (no. of persons);Industry and Construction;4,929
Personnel in R&D in biotechnology (no. of persons);Agriculture;1,032
Personnel in R&D in biotechnology (no. of persons): Research personnel;Total Companies;8,380
Personnel in R&D in biotechnology (no. of persons): Research personnel;Services;6,054
Personnel in R&D in biotechnology (no. of persons): Research personnel;Industry and Construction;2,067
Personnel in R&D in biotechnology (no. of persons): Research personnel;Agriculture;259
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Total Companies;7,364
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Services;3,729
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Industry and Construction;2,862
Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel;Agriculture;773
Personnel in R&D in biotechnology (no. of persons). Women;Total Companies;8,725
Personnel in R&D in biotechnology (no. of persons). Women;Services;5,567
Personnel in R&D in biotechnology (no. of persons). Women;Industry and Construction;2,720
Personnel in R&D in biotechnology (no. of persons). Women;Agriculture;438
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Total Companies;4,521
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Services;3,331
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Industry and Construction;1,085
Personnel in R&D in biotechnology (no. of persons). Women: Research personnel;Agriculture;104
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Total Companies;4,204
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Services;2,236
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Industry and Construction;1,635
Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel;Agriculture;334
Personnel in R&D in biotechnology (FTE);Total Companies;11,523.2
Personnel in R&D in biotechnology (FTE);Services;7,360.5
Personnel in R&D in biotechnology (FTE);Industry and Construction;3,555.3
Personnel in R&D in biotechnology (FTE);Agriculture;607.5
Personnel in R&D in biotechnology (FTE): Research personnel;Total Companies;6,341.6
Personnel in R&D in biotechnology (FTE): Research personnel;Services;4,606.5
Personnel in R&D in biotechnology (FTE): Research personnel;Industry and Construction;1,557.7
Personnel in R&D in biotechnology (FTE): Research personnel;Agriculture;177.3
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Total Companies;5,181.6
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Services;2,753.9
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Industry and Construction;1,997.6
Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel;Agriculture;430.2
Personnel in R&D in biotechnology (FTE). Women;Total Companies;6,552.7
Personnel in R&D in biotechnology (FTE). Women;Services;4,194.8
Personnel in R&D in biotechnology (FTE). Women;Industry and Construction;2,088.7
Personnel in R&D in biotechnology (FTE). Women;Agriculture;269.2
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Total Companies;3,464.4
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Services;2,518.3
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Industry and Construction;872.8
Personnel in R&D in biotechnology (FTE). Women: Research personnel;Agriculture;73.3
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Total Companies;3,088.3
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Services;1,676.5
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Industry and Construction;1,215.9
Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel;Agriculture;195.9
Internal expenditure on R&D (thousands of euros);Total Companies;1,037,887
Internal expenditure on R&D (thousands of euros);Services;632,044
Internal expenditure on R&D (thousands of euros);Industry and Construction;365,151
Internal expenditure on R&D (thousands of euros);Agriculture;40,692
1) By nature of the expense: Current expenses;Total Companies;939,471
1) By nature of the expense: Current expenses;Services;572,886
1) By nature of the expense: Current expenses;Industry and Construction;329,570
1) By nature of the expense: Current expenses;Agriculture;37,015
1.1) Remuneration to research personnel;Total Companies;321,525
1.1) Remuneration to research personnel;Services;220,159
1.1) Remuneration to research personnel;Industry and Construction;91,852
1.1) Remuneration to research personnel;Agriculture;9,514
1.2) Remuneration to technical and auxiliary personnel;Total Companies;194,656
1.2) Remuneration to technical and auxiliary personnel;Services;95,001
1.2) Remuneration to technical and auxiliary personnel;Industry and Construction;86,840
1.2) Remuneration to technical and auxiliary personnel;Agriculture;12,816
1.3) Other current expenses;Total Companies;423,290
1.3) Other current expenses;Services;257,726
1.3) Other current expenses;Industry and Construction;150,878
1.3) Other current expenses;Agriculture;14,686
2) By nature of the expense: Capital expenses;Total Companies;98,416
2) By nature of the expense: Capital expenses;Services;59,158
2) By nature of the expense: Capital expenses;Industry and Construction;35,581
2) By nature of the expense: Capital expenses;Agriculture;3,677
2.1) Land and buildings;Total Companies;10,150
2.1) Land and buildings;Services;6,669
2.1) Land and buildings;Industry and Construction;2,905
2.1) Land and buildings;Agriculture;577
2.2) Equipment and instruments;Total Companies;72,538
2.2) Equipment and instruments;Services;40,536
2.2) Equipment and instruments;Industry and Construction;30,157
2.2) Equipment and instruments;Agriculture;1,845
2.3) Acquisition of specific R&D software;Total Companies;5,713
2.3) Acquisition of specific R&D software;Services;3,849
2.3) Acquisition of specific R&D software;Industry and Construction;1,726
2.3) Acquisition of specific R&D software;Agriculture;138
2.4) Otros productos de propiedad intelectual específicos para I+D;Total Companies;10,015
2.4) Otros productos de propiedad intelectual específicos para I+D;Services;8,104
2.4) Otros productos de propiedad intelectual específicos para I+D;Industry and Construction;794
2.4) Otros productos de propiedad intelectual específicos para I+D;Agriculture;1,117
1.1) By origin of the funds: Own funds;Total Companies;711,037
1.1) By origin of the funds: Own funds;Services;360,440
1.1) By origin of the funds: Own funds;Industry and Construction;315,867
1.1) By origin of the funds: Own funds;Agriculture;34,730
1.2) By origin of the funds: From companies;Total Companies;121,595
1.2) By origin of the funds: From companies;Services;109,172
1.2) By origin of the funds: From companies;Industry and Construction;7,824
1.2) By origin of the funds: From companies;Agriculture;4,600
1.3) By origin of the funds: Public Administration funds;Total Companies;107,422
1.3) By origin of the funds: Public Administration funds;Services;91,468
1.3) By origin of the funds: Public Administration funds;Industry and Construction;14,662
1.3) By origin of the funds: Public Administration funds;Agriculture;1,292
1.4) By origin of the funds: From Universities;Total Companies;192
1.4) By origin of the funds: From Universities;Services;182
1.4) By origin of the funds: From Universities;Industry and Construction;11
1.4) By origin of the funds: From Universities;Agriculture;0
1.5) By origin of the funds: From non profit private institutions;Total Companies;10,756
1.5) By origin of the funds: From non profit private institutions;Services;10,585
1.5) By origin of the funds: From non profit private institutions;Industry and Construction;171
1.5) By origin of the funds: From non profit private institutions;Agriculture;0
1.6) By origin of the funds: Foreign funds;Total Companies;86,884
1.6) By origin of the funds: Foreign funds;Services;60,196
1.6) By origin of the funds: Foreign funds;Industry and Construction;26,617
1.6) By origin of the funds: Foreign funds;Agriculture;70
Purchase of R&D services in biotechnology (thousands of euros);Total Companies;145,440
Purchase of R&D services in biotechnology (thousands of euros);Services;75,379
Purchase of R&D services in biotechnology (thousands of euros);Industry and Construction;68,977
Purchase of R&D services in biotechnology (thousands of euros);Agriculture;1,085
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Total Companies;95,870
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Services;52,783
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Industry and Construction;42,361
Purchase of R&D services in biotechnology (thousands of euros): In Spain;Agriculture;726
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Total Companies;49,570
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Services;22,595
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Industry and Construction;26,616
Purchase of R&D services in biotechnology (thousands of euros): Abroad;Agriculture;359
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total Companies;39.8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Services;48.3
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Industry and Construction;26.8
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Agriculture;25.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total Companies;12.5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Services;12.2
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Industry and Construction;13.6
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Agriculture;10.0
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total Companies;18.5
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Services;19.9
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Industry and Construction;16.4
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Agriculture;16.0
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total Companies;11.2
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Services;11.4
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Industry and Construction;10.8
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Agriculture;11.9
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total Companies;15.6
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Services;18.0
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Industry and Construction;11.7
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Agriculture;12.0
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Total Companies;16.5
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Services;19.9
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Industry and Construction;10.7
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels;Agriculture;13.9
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total Companies;16.1
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Services;16.3
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Industry and Construction;15.7
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Agriculture;15.8
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total Companies;40.0
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Services;43.1
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Industry and Construction;34.9
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Agriculture;37.0
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Total Companies;53.9
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Services;57.8
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Industry and Construction;46.9
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Agriculture;51.9
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total Companies;21.5
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Services;22.1
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Industry and Construction;19.0
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Agriculture;26.8
% Companies with income of an international origin related to biotechnological activities;Total Companies;22.2
% Companies with income of an international origin related to biotechnological activities;Services;24.1
% Companies with income of an international origin related to biotechnological activities;Industry and Construction;22.3
% Companies with income of an international origin related to biotechnological activities;Agriculture;7.0
% Turnover representing income of an international origin related to biotechnological activities;Total Companies;1.9
% Turnover representing income of an international origin related to biotechnological activities;Services;5.8
% Turnover representing income of an international origin related to biotechnological activities;Industry and Construction;1.5
% Turnover representing income of an international origin related to biotechnological activities;Agriculture;2.4
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Total Companies;65.5
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Services;60.2
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Industry and Construction;67.5
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU;Agriculture;68.3
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Total Companies;34.5
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Services;39.8
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Industry and Construction;32.5
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries;Agriculture;31.7
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Total Companies;86.3
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Services;84.0
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Industry and Construction;87.3
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services;Agriculture;85.0
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Total Companies;12.2
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Services;11.9
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Industry and Construction;12.6
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain;Agriculture;0.0
% Income of an international origin related with activities according to the classification: Operating source abroad;Total Companies;1.1
% Income of an international origin related with activities according to the classification: Operating source abroad;Services;3.8
% Income of an international origin related with activities according to the classification: Operating source abroad;Industry and Construction;0.1
% Income of an international origin related with activities according to the classification: Operating source abroad;Agriculture;0.0
% Income of an international origin related with activities according to the classification: Other;Total Companies;0.4
% Income of an international origin related with activities according to the classification: Other;Services;0.3
% Income of an international origin related with activities according to the classification: Other;Industry and Construction;0.0
% Income of an international origin related with activities according to the classification: Other;Agriculture;15.0